Hologic expects to report total revenues of approximately $1.074B, a decrease of (27.0%) compared to the prior year period, or (25.1%) in constant currency. Consensus at $966.37M. These preliminary results are higher than the company’s most recent revenue guidance range of $940M- $990M, which was provided on October 31, 2022. Hologic has not yet completed its financial close processes for the first quarter of fiscal 2023, therefore GAAP financial results for the quarter have not yet been finalized. However, the company expects non-GAAP diluted earnings per share to be above the guidance range of 80c-90c provided on October 31, 2022.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on HOLX: